GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen Smith, MD
Quince Therapeutics Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
93 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital de Brabois
Toulouse, Cedex, France
- Centre de Ressources Biologiques
Lille, France
- University Hospital la Timone, Department of Neurology and Neuropsychology
Marseille, France
- Service de Gériatrie
Nice, France
- Hôpitaux Universitaires de Strasbourg, Centre D'Investigation Clinique, Hôpital Hautepierre
Strasbourg, France
- Chru de Nancy Hôpital de Brabois Service de Gériatrie
Vandœuvre-lès-Nancy, France
- Brain Research Center Den Bosch B.V.
's-Hertogenbosch, Netherlands
- Brain Research Center
Amsterdam, Netherlands
- Precare Trial & Recruitment
Beek, Netherlands
- Brain Research Center Zwolle
Zwolle, Netherlands
- Isala Zwolle - Interne Geneeskunde Centrum Voor Ouderengeneeskunde
Zwolle, Netherlands
- Indywidualna Specjalistyczna Praktyka Lekarska
Gdansk, Poland
- Nzoz Wielospecjalistyczna Poradnia Lekarska Synapsis
Katowice, Poland
- Krakowska Akademia Neurologii
Krakow, Poland
- Neuro-Care Sp. Z O.O. Sp. Komandytowa
Siemianowice Śląskie, Poland
- Euromedis Sp. Z O.O.
Szczecin, Poland
- Centrum Medyczne Neuroprotect
Warsaw, Poland
- Nzoz Wrocławskie Centrum Alzheimerowskie
Wroclaw, Poland
- Policlinica Gipuzkoa
San Sebastián, Gipuzkoa, Spain
- Hospital General de Alicante
Alicante, Spain
- Fundacio Ace
Barcelona, Spain
- Hospital Clinic de Barcelona
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Hospital Universitario Ramón Y Cajal
Madrid, Spain
- Hospital Universitari General de Catalunya
Sant Cugat del Vallès, Spain
- Hospital Universitario Marqués de Valdecilla
Santander, Spain
- Cognition Health Birmingham (private)
Edgbaston, Birmingham, United Kingdom
- St Pancras Clinical Research (private)
Barbican, London, United Kingdom
- Cognition Health Plymouth
Plymouth, Science Park, United Kingdom
- Memory Assessment and Research Centre, Moorgreen Hospital
Southampton, UK, United Kingdom
- Rice - the Research Institute for the Care of Older People
Bath, United Kingdom
- Glasgow Memory Clinic
Glasgow, United Kingdom
- Cognition Health Ltd. (private) Guildford
Guildford, United Kingdom
- Cognition Health Ltd. (private) London
London, United Kingdom
- Kingshill Research Centre Swindon
Swindon, United Kingdom
- Banner Alzheimer'S Institute
Phoenix, Arizona, United States
- Xenoscience, Inc.
Phoenix, Arizona, United States
- Banner Sun Health
Sun City, Arizona, United States
- Atp Clinical Research, Inc.
Costa Mesa, California, United States
- Alliance Research
Long Beach, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Mar 2019
- Primary completion
- 1 Jan 2022
- Completion
- 1 Jan 2022
- Last update posted
- 23 Feb 2023
- Registered enrollment
- 643
- Registry id
- NCT03823404
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.